CYCC Bio Green Med Solution Inc.


$ 1.27 $ -0.03 (-2.36 %)    

Thursday, 20-Nov-2025 15:25:50 EST
QQQ $ 585.49 $ -26.43 (-4.32 %)
DIA $ 457.91 $ -8.76 (-1.88 %)
SPY $ 652.55 $ -20.53 (-3.05 %)
TLT $ 89.29 $ 0.30 (0.34 %)
GLD $ 374.85 $ -0.33 (-0.09 %)
$ 1.29
$ 1.27
$ 1.23 x 8
$ 1.29 x 38
$ 1.24 - $ 1.30
$ 1.19 - $ 101.30
42,638
na
na
$ 1.29
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION